Project Description
On July 2, Takeda Pharmaceutical Company Limited, (“Takeda”) held the grand opening of Takeda Global Headquarters. The building, completed in March 2018, will serve as Takeda’s head office for its operations worldwide. At the grand opening, Creative Director Kashiwa Sato (SAMURAI, Inc.), Takeda’s President and CEO Christophe Weber, and Takeda’s Head of Corporate Strategy and the CEO Office, Yasuhiro Fukutomi, who managed the project, took to the stage to introduce the objectives and significance of the project as the company accelerates its transformation. “Takeda Global Headquarters symbolizes the passing on to the next generation of Takeda’s unwavering identity and values as a company, with its roots in Japan, yet reaching patients worldwide,” said Takeda President and CEO Weber. “Moreover, it will provide a base for our diverse workforce of around 30,000 employees across the globe where they can connect, collaborate, learn and share, in an environment designed to offer comfort and inspiration. From here in Nihonbashi, Tokyo, we will pursue our mission of contributing to better health and a brighter future for people worldwide, while nurturing our relationship with the local community” Kashiwa Sato said “I wanted the design of Takeda’s new headquarters to express the essence of Takeda’s values, and its core commitment to always put patients first. In this process, I chose “life force” as the central concept, and the eight characters for “life”, “water”, “light”, “earth”, “trees”, “people”, “connections”, and “future” as motifs, representing this concept. Just as these basic natural elements form the wellspring that nurtures life, the bonds between people are the driving-force that enable them to tackle the biggest of challenges, and contribute to a brighter future for all. It is my hope that this building will be an inspiration to all who work here as well as to the visitors, and it will lead them to naturally want to share their thoughts on Takeda’s future.” With Takeda Global Headquarters as a base, and a symbol of our values, we will further accelerate our transformation into becoming a global, values-based R&D-driven biopharmaceutical leader.